HC
NTUS

Henshaw Capital’s Natus Medical Inc NTUS Stock Holding History

Henshaw Capital’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-6,995
Closed -$249K – 347
2018
Q3 		$249K Sell
6,995
-2,095
-23% -$74K 0.02% 258
2018
Q2 		$314K Buy
+9,090
New +$319K 0.03% 230

Other funds holding NTUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Henshaw Capital's NTUS Position: Q4 2018 in Review

Henshaw Capital sold out of Natus Medical Inc (NTUS) in Q4 2018, closing a stake of 6,995 shares — an estimated $249K sold.

Henshaw Capital first reported a position in NTUS in Q2 2018 and held it in 2 quarters. The position peaked at $314K in Q2 2018. 174 funds tracked by Wall St. Rank hold NTUS as of Q4 2018.

  • Henshaw Capital reported no remaining Natus Medical Inc position as of Q4 2018 after selling out during the quarter.
  • Henshaw Capital sold 6,995 Natus Medical Inc shares in Q4 2018, an estimated $249K.
  • Henshaw Capital first reported a position in Natus Medical Inc in Q2 2018 and held it in 2 quarters.
  • Henshaw Capital's Natus Medical Inc position peaked at $314K in Q2 2018.
  • 174 funds tracked by Wall St. Rank held Natus Medical Inc as of Q4 2018.

Based on Henshaw Capital's 13F filing for Q4 2018, filed 28 May 2026.